Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Cantor Fitzgerald
Fuji
Boehringer Ingelheim
Queensland Health
Medtronic
Baxter
Citi

Generated: July 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077462

« Back to Dashboard

NDA 077462 describes NATEGLINIDE, which is a drug marketed by Alvogen Malta, Dr Reddys Labs Ltd, Par Pharm, Teva Pharms, Watson Labs, Wilshire Pharms Inc, and Zydus Pharms Usa Inc, and is included in seven NDAs. It is available from ten suppliers. Additional details are available on the NATEGLINIDE profile page.

The generic ingredient in NATEGLINIDE is nateglinide. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nateglinide profile page.
Summary for 077462
Tradename:NATEGLINIDE
Applicant:Watson Labs
Ingredient:nateglinide
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Pharmacology for NDA: 077462
Mechanism of ActionPotassium Channel Antagonists
Suppliers and Packaging for NDA: 077462
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATEGLINIDE nateglinide TABLET;ORAL 077462 ANDA Actavis Pharma, Inc. 0591-3354 N 0591-3354-01
NATEGLINIDE nateglinide TABLET;ORAL 077462 ANDA Actavis Pharma, Inc. 0591-3355 N 0591-3355-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Mar 30, 2011TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength120MG
Approval Date:Mar 30, 2011TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Merck
QuintilesIMS
Baxter
UBS
Argus Health
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.